Dyadic Logo Current.jpg
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
28 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
Global IL-17 Biologics Market
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
20 févr. 2024 10h57 HE | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Dyadic Logo Current.jpg
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
01 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
22157.jpg
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Industry Forecast to 2032: U.S. Projected to Maintain Dominance, Driven by Innovative Therapies Entering the Market
30 janv. 2024 07h43 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032" report has been added to ...
22157.jpg
Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs
25 janv. 2024 09h54 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
22157.jpg
Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2031
25 janv. 2024 09h50 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
22157.jpg
Antibody Therapeutics Industry to Reach $631.3 Billion by 2030: Global Market Analysis, Unveiling the Strategies of Leading Players Roche, AbbVie, J&J, and Merck Among Others
24 janv. 2024 13h49 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market Size, Share & Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Primary Immunodeficiency Therapeutics Market to Surpass $11 Billion by 2030 with Significant Advancement in Genetic Research and Diagnostic Technologies
24 janv. 2024 12h27 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Primary Immunodeficiency Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
22157.jpg
Global Research Antibodies and Reagents Analysis Report 2023-2030: Emphasis on Proteomics and Genomics Research to Propel Demand
24 janv. 2024 07h02 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies and Reagents Market 2023 - 2030 by Technology, Application, End-user, Product - Partner & Customer Ecosystem Competitive...
Global Research Antibodies Market
Global Research Antibodies Analysis Report 2024: Emerging Opportunities with Expansion into Emerging Countries and Development of Novel Research Antibodies - Forecasts to 2028
17 janv. 2024 04h23 HE | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering. The global market for research antibodies was...